Abstract

Basics of Compounding for Cough

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2004 - Endotoxin

Page(s): 462-465

Download in electronic PDF format for $75
  • Basics of Compounding for Cough Page 1
  • Basics of Compounding for Cough Page 2
  • Basics of Compounding for Cough Page 3
  • Basics of Compounding for Cough Page 4

Abstract

Cough is a symptom of a number of pathologic conditions, including infections and pulmonary, cardiac, and gastrointestinal disorders. It also can be caused by medication. While numerous prescription and nonprescription treatments for cough are available, these are not suitable for all patients in all situations. Extemporaneous compounding allows preparation of customized formulations that contains a variety of difference components in a dosage form convenient for the patient. Formulas and methods are provided for several frequently prescribed compounds. The initial step in treating cough is eliminating exposure to any irritant or discontinuing any medication that might be causing the cough. Depending on the cause of the cough, drug therapies include antihistamines (with or without decongestant), intranasal or oral corticosteroids, antibiotics, bronchodilators, topical volatile agents (eg, camphor, menthol, thymol), guaifenesin (antitussive/expectorant), or centrally acting drugs that suppress the cough reflex (codeine sulfate, dextromorphan hydrobromide, hydrocodone bitartrate, hydromorphone hydrochloride).

Related Keywords

  • continuing education
  • coughing
  • bronchial secretions
  • antitussive effects
  • central suppression
  • medication side effect
  • formulation: dextromorphan 30-mg capsules
  • formulation: terpin hydrate and codeine elixir
  • formulation: guaifenesin 100 mg/5 mL and promethazine hydrochloride 10 mg/5 mL cough syrup
  • formulation: dextromorphan hydrobromide 20-mg lollipops with menthol and eucalyptus oil
  • formulation: hydrocodone 5-mg or hydromorphone 1-mg troches
  • formulation: codeine sulfate 15-mg suppositories
  • formulation: dextromorphan 30-mg suppositories
  • formulation: inhalant volatiles for vaporizers

Related Categories

  • FORMULATIONS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2003
Pg. 129-134
View Sample
Basics of Compounding for Terrorist Attacks, Part 2
Author(s): Allen Loyd V Jr
Sep/Oct 2001
Pg. 401-405
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release
Author(s): Bogner Robin H, Szwejkowski Jessica, Houston Alana
Nov/Dec 2015
Pg. 504
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules
Author(s): Allen Loyd V Jr
Nov/Dec 2012
Pg. 480-483
Colds and Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2005
Pg. 388
Aspirin 380-mg, Caffeine 30-mg, and Codeine Phosphate 30-mg Capsules
Author(s): Allen Loyd V Jr
Sep/Oct 2005
Pg. 386
Acetaminophen 400-mg, Aspirin 250-mg, Codeine Phosphate 30-mg with Antacids Capsules
Author(s): Allen Loyd V Jr
Sep/Oct 2005
Pg. 387
Acetaminophen 325-mg, Codeine Phosphate 32.5-mg, and Phenyltoloxamine Citrate 30-mg Capsules
Author(s): Allen Loyd V Jr
Nov/Dec 2022
Pg. 516-521
Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Author(s): Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
May/Jun 2013
Pg. 247-253
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Mar/Apr 2010
Pg. 105-107
Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword?
Author(s): Williams LaVonn A
Mar/Apr 2010
Pg. 171-173
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
May/Jun 2009
Pg. 224-229
Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education
Author(s): McElhiney Linda F
Jan/Feb 2017
Pg. 6-16
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Author(s): Deleruyelle Laura J
Jul/Aug 2003
Pg. 304
Triprolidine HCl 1.25-mg/5-mL, Pseudoephedrine HCl 30-mg/5-mL and Codeine Phosphate 10-mg/5-mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 1999
Pg. 291-294
The Basics of Compounding: Compounding Special Capsules
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 388-392
Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Author(s): Allen Loyd V Jr
Jan/Feb 2002
Pg. 46
Ketoprofen 12.5-mg, Phenyltoloxamine Citrate 30-mg, and Caffeine 30-mg Capsules
Author(s): Allen Loyd V Jr